Colchicine for narrowed brain arteries after recent stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 2 trial tests whether colchicine can help people with significant narrowing in brain arteries (from atherosclerosis) after a recent stroke or “mini-stroke.” It aims to reduce the risk related to this condition during the early period after symptoms begin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re Chinese and between 40 and 80 years old
- You had a first-ever ischemic stroke within 8 weeks before joining
- Your brain artery narrowing is at least 50% in specific arteries (middle cerebral or basilar), caused by atherosclerosis
- Your stroke or mini-stroke matched the blood vessel area affected (symptoms in the last 8 weeks)
- You must be able to give informed consent and complete brain scans (CTA/MRI/DSA if needed)
- You must not have conditions that make colchicine unsafe (for example kidney disease, certain blood problems, chronic diarrhea/IBD, colchicine allergy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a drug called colchicine can reduce the risk of future strokes and improve recovery after a recent brain bleed (intracerebral hemorrhage). It is for people who also have heart or blood vessel disease or multiple risk factors like high blood pressure or diabetes.
This trial tests whether the anti-inflammatory drug colchicine can help prevent a second stroke in people who recently had a mild to moderate ischemic stroke. If you had a stroke 1 to 4 weeks ago and are between 18 and 80 years old, you may be able to join.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
This trial tests whether colchicine (a medicine commonly used for inflammation) can improve how well clogged heart arteries reopen after a short-term heart emergency called ACS. You may be eligible if you’re hospitalized with ACS and are planned for a coronary angiogram and possible angioplasty soon.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
Hear when a new ICAD - Intracranial Atherosclerotic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.